TY - JOUR
T1 - Possible delayed cut-end recurrence after limited resection for ground-glass opacity adenocarcinoma, Intraoperatively diagnosed as noguchi type B, in three patients
AU - Yoshida, Junji
AU - Ishii, Genichiro
AU - Yokose, Tomoyuki
AU - Aokage, Keiju
AU - Hishida, Tomoyuki
AU - Nishimura, Mitsuyo
AU - Onuki, Takuya
AU - Noguchi, Masayuki
AU - Nagai, Kanji
PY - 2010/4
Y1 - 2010/4
N2 - INTRODUCTION:: In our limited resection trial of pulmonary peripheral ground-glass opacity (GGO) lesions from 1998 to 2002, limited resection of Noguchi type A and B carcinomas seemed to have a positive outcome. However, recently three of the 24 patients, with mixed GGO lesions intraoperatively diagnosed as type B, developed a solid lesion at the cut-end scar. METHODS:: Medical records and radiology and pathology findings of the three patients were reviewed. We also analyzed epidermal growth factor receptor gene mutations when possible. RESULTS:: Radiologically, these three second tumors were clearly cut-end scar area recurrences. However, other pathologic and mutation findings suggest metachronous primary cancers developed in Case 1, cut-end recurrence in Case 2, and needle biopsy implantation in Case 3. It is difficult to definitively conclude whether the second tumors were recurrences or metachronous primaries. CONCLUSIONS:: These second tumors have convinced us that our initial caution in concluding GGO lesions can be cured by limited resection was very appropriate. The recurrences definitely indicate that continuing follow-up attention for more than 5 years is needed after limited resection even for GGO bronchioloalveolar carcinomas.
AB - INTRODUCTION:: In our limited resection trial of pulmonary peripheral ground-glass opacity (GGO) lesions from 1998 to 2002, limited resection of Noguchi type A and B carcinomas seemed to have a positive outcome. However, recently three of the 24 patients, with mixed GGO lesions intraoperatively diagnosed as type B, developed a solid lesion at the cut-end scar. METHODS:: Medical records and radiology and pathology findings of the three patients were reviewed. We also analyzed epidermal growth factor receptor gene mutations when possible. RESULTS:: Radiologically, these three second tumors were clearly cut-end scar area recurrences. However, other pathologic and mutation findings suggest metachronous primary cancers developed in Case 1, cut-end recurrence in Case 2, and needle biopsy implantation in Case 3. It is difficult to definitively conclude whether the second tumors were recurrences or metachronous primaries. CONCLUSIONS:: These second tumors have convinced us that our initial caution in concluding GGO lesions can be cured by limited resection was very appropriate. The recurrences definitely indicate that continuing follow-up attention for more than 5 years is needed after limited resection even for GGO bronchioloalveolar carcinomas.
UR - http://www.scopus.com/inward/record.url?scp=77950997290&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77950997290&partnerID=8YFLogxK
U2 - 10.1097/JTO.0b013e3181d0a480
DO - 10.1097/JTO.0b013e3181d0a480
M3 - Article
C2 - 20357619
AN - SCOPUS:77950997290
SN - 1556-0864
VL - 5
SP - 546
EP - 550
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 4
ER -